Chromatin states encoding fate commitment and plasticity of tolerant CD8 T cells
Chromatin states encoding fate commitment and plasticity of tolerant CD8 T cells
批准号:
8568389
负责人:
PHILIP D GREENBERG
金额:
$18.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-06-01 至 2015-05-31
关键词:
Antigen PresentationAntigensAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityBerylliumCD8B1 geneCell CycleCell physiologyCellsChromatinClinicalComplexCuesDNADNA MethylationDNA Modification ProcessDNA SequenceDevelopmentEncyclopedia of DNA ElementsEnhancersEnvironmentEpigenetic ProcessExhibitsFailureFunctional RNAGene ExpressionGene Expression ProfileGenerationsGenesGeneticGenetic TranscriptionGraft RejectionImmuneImmunotherapeutic agentIndividualInflammatoryInjuryLeadLeftListeriosisLymphopeniaMaintenanceMalignant NeoplasmsMediatingMemoryMethodsMicroRNAsNatureNucleosomesOrganismPatternPhenotypePreventionProliferatingPromoter RegionsProteinsRegulatory ElementResolutionRoleScienceSelf ToleranceSignal PathwaySignal TransductionStimulusT cell differentiationT cell responseT-LymphocyteTechnologyTherapeuticTolerogenTranscriptTransplantationTransplanted tissueTumor AntigensWorkcancer immunotherapychromatin modificationepigenomegenome-wide analysishistone modificationimprintin vivonovelpreventprogramspublic health relevanceresponsetranscription factortumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Most CD8 T cells reactive with self-antigens are deleted during thymic development, and the cells that evade elimination must be rendered tolerant in the periphery to prevent autoimmune injury. However, many candidate cancer antigens are self-antigens, and tolerance to these proteins can impede anti-tumor T cell responses. We recently demonstrated that such self/tumor-antigen specific CD8 T cells harbor a tolerance- specific gene program associated with functional unresponsiveness reflected by their inability to proliferate in response to antigen, lack key transcription factors and molecules needed for effector function(s), and express genes associated with reduced immune cell function. However, tolerance is not an irreversible, fixed differentiation state: the tolerance gen program can be temporarily overridden during periods of lymphopenia- induced homeostatic proliferation (HP) in vivo, resulting in rescue of antigen responsiveness and function. Once the proliferative drive of HP ends and T cells exit the cell cycle, the tolerance gene signature is re-
imposed regardless of whether the cells re-encounter the tolerizing self-antigen. These findings demonstrate that continuous antigen exposure is not required to maintain tolerance, and suggest that self-tolerant T cells "remember" the tolerance program established during the initial encounter(s) with self-antigen in the periphery. Our specific hypothesis is that self-tolerance represents a unique differentiation state that is maintained by a "tolerance-specific" program epigenetically imprinted through "tolerance-specific" chromatin marks and regulatory elements. Epigenetic regulatory mechanisms of gene expression are just beginning to be understood, in part through recent work by The Encyclopedia of DNA elements (ENCODE) project, revealing new relationships between chromatin accessibility, gene expression, DNA-methylation and regulatory factor occupancy patterns, and identifying novel cis-regulatory motifs of transcription factor. The proposed studies will determine the chromatin states associated with distinct CD8 T cell differentiation and functional states to define the epigenetic underpinnings of commitment fate and plasticity of self-tolerant and functional T cells. Elucidating how chromatin states encode and maintain the tolerant state may not only identify interventional clinical opportunities for cancer immunotherapy, but also suggest strategies for mitigating the dangers of autoimmunity and transplant rejection. The Specific Aims are to: 1) Define the cell-intrinsic regulatory mechanism(s) associated with the establishment and maintenance of self-tolerance by using ENCODE technologies with comprehensive, high- resolution genome-wide analysis of chromatin states to identify the epigenetic program uniquely encoded in tolerant T cells; and 2) Determine the underlying mechanism(s) and strategies by which tolerance imprinting and epigenetic memory can be erased to achieve permanent re-programming associated with long-term rescue and differentiation of self/tumor-specific CD8 T cells into functional antigen-responsive T cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 1: Transgenic TCR-mediated tumor therapy
-
批准号:10380817
-
项目类别:
-
资助金额:$89.93万
-
财政年份:2019
-
负责人:PHILIP D GREENBERG
-
依托单位:
Project 1: Transgenic TCR-mediated tumor therapy
-
批准号:10629190
-
项目类别:
-
资助金额:$57.96万
-
财政年份:2019
-
负责人:PHILIP D GREENBERG
-
依托单位:
Chromatin states encoding fate commitment and plasticity of tolerant CD8 T cells
-
批准号:8667993
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2013
-
负责人:PHILIP D GREENBERG
-
依托单位:
Specific Adoptive Immunotherapy of Leukemia
-
批准号:8277821
-
项目类别:
-
资助金额:$57.97万
-
财政年份:2011
-
负责人:PHILIP D GREENBERG
-
依托单位:
SAFETY AND ANTIVIRAL EFFICACY OF IMMUNOTHERAPY WITH AUTOLOGOUS CD8+ HIV-SPECIFIC
-
批准号:7603503
-
项目类别:
-
资助金额:$0.96万
-
财政年份:2007
-
负责人:PHILIP D GREENBERG
-
依托单位:
ADOPTIVE TRANSFER OF SHIV-SPECIFIC CD8+ T CELLS
-
批准号:7349352
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2006
-
负责人:PHILIP D GREENBERG
-
依托单位:
Specific Adoptive Immunotherapy of Leukemia
-
批准号:7226430
-
项目类别:
-
资助金额:$48.06万
-
财政年份:2006
-
负责人:PHILIP D GREENBERG
-
依托单位:
ADOPTIVE TRANSFER OF AUTOLOGOUS SHIV-SPECIFIC CD+-T CELLS
-
批准号:7165778
-
项目类别:
-
资助金额:$17.58万
-
财政年份:2005
-
负责人:PHILIP D GREENBERG
-
依托单位:
ADOPTIVE TRANSFER OF AUTOLOGOUS SHIV-SPECIFIC CD+-T CELLS
-
批准号:6971679
-
项目类别:
-
资助金额:$13.44万
-
财政年份:2004
-
负责人:PHILIP D GREENBERG
-
依托单位:
Biologic Activity of Transferred HIV-specific CD8 Clones
-
批准号:6723761
-
项目类别:
-
资助金额:$57.72万
-
财政年份:2003
-
负责人:PHILIP D GREENBERG
-
依托单位:
ADOPTIVE TRANSFER OF AUTOLOGOUS SHIV-SPECIFIC CD*+-T CELLS
-
批准号:6940072
-
项目类别:
-
资助金额:$6.77万
-
财政年份:2003
-
负责人:PHILIP D GREENBERG
-
依托单位:
Biologic Activity of Transferred HIV-specific CD8 Clones
-
批准号:6590096
-
项目类别:
-
资助金额:$57.86万
-
财政年份:2003
-
负责人:PHILIP D GREENBERG
-
依托单位:
Biologic Activity of Transferred HIV-specific CD8 Clones
-
批准号:6884838
-
项目类别:
-
资助金额:$59.17万
-
财政年份:2003
-
负责人:PHILIP D GREENBERG
-
依托单位:
Biologic Activity of Transferred HIV-specific CD8 Clones
-
批准号:7494309
-
项目类别:
-
资助金额:$21.47万
-
财政年份:2003
-
负责人:PHILIP D GREENBERG
-
依托单位:
ENHANCEMENT OF IMMUNE RESPONSIVENESS TO VACC. BY TREATMENT WITH ANTI-CTLA-4
-
批准号:6940071
-
项目类别:
-
资助金额:$6.77万
-
财政年份:2003
-
负责人:PHILIP D GREENBERG
-
依托单位:
Biologic Activity of Transferred HIV-specific CD8 Clones
-
批准号:7050101
-
项目类别:
-
资助金额:$59.14万
-
财政年份:2003
-
负责人:PHILIP D GREENBERG
-
依托单位:
CELLULAR IMMUNE RESPONSES TO SUBUNIT IMMUNODEFICIENCY VIRUS VACCINES
-
批准号:6299486
-
项目类别:
-
资助金额:$34.34万
-
财政年份:2000
-
负责人:PHILIP D GREENBERG
-
依托单位:
SPECIFIC ADOPTIVE IMMUNOTHERAPY OF VIRAL DISEASES
-
批准号:6300132
-
项目类别:
-
资助金额:$34.64万
-
财政年份:2000
-
负责人:PHILIP D GREENBERG
-
依托单位:
TRANSFER OF HIV-SPECIFIC CD4+ T CELL CLONES WITH GENES INHIBITING HIV
-
批准号:6344654
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2000
-
负责人:PHILIP D GREENBERG
-
依托单位:
CORE--MOLECULAR IMMUNOLOGY
-
批准号:6299614
-
项目类别:
-
资助金额:$17.84万
-
财政年份:2000
-
负责人:PHILIP D GREENBERG
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: